← United States · Coverage record
US · SEC FORM 4
TREACE MEDICAL CONCEPTS, INC.
TMCI · Nasdaq · CIK 0001630627 · Healthcare · Medical Devices
INSIDER SIGNAL
1 buyers · 14 purchase transaction lines · $1.5M gross purchase
WHY THIS SIGNAL?
Score anatomy
Each bar shows the contribution to the current score; the weights and formula stay unchanged.
What is holding the score back?
- ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
- ⚠ Role scores low · most senior buyer: Chief Executive Officer (CEO, chair and 10% owners score lowest)
- ⚠ Purchase activity is becoming less recent
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.
Purchase breadth & concentration
Roles in the peak window: Chief Executive Officer. Concentration uses priced qualifying P lines only and does not change the saved score.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 4 additional owner(s) remain in Form 4 evidence.
SIGNAL HISTORY
Latest recorded score
- 53.4
- 53.3
- 53.2
- 53.0
- 53.0
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.
Price performance
- 1M
- -9.2%
- 3M
- -13.8%
- 6M
- +118.2%
- 12M
- -35.9%
Volatility & liquidity
- Volatility
- 76.5%
- Beta
- —
- Avg daily value
- USD 1.2M
Valuation
- Market cap
- USD 256.9M
- P/E
- —
Fundamentals
- Profit margin
- -27.7%
- ROE
- -67.6%
- Industry
- Medical Devices
Market data
Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, Profit margin, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-07-31 · Status: PASS
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 1,976,907
- Previous report
- 1,736,595
- Avg daily volume
- 229,942
- Days to cover
- 8.6
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-24 | Treace John T. | Purchase (P) | Common Stock | 11,000 | USD 4.34 | USD 47,740 | SEC filing ↗ |
| 2026-08-21 | Treace John T. | Purchase (P) | Common Stock | 5,000 | USD 4.35 | USD 21,750 | SEC filing ↗ |
| 2026-08-20 | Treace John T. | Purchase (P) | Common Stock | 39,944 | USD 4.44 | USD 177,351 | SEC filing ↗ |
| 2026-06-11 | Treace John T. | Purchase (P) | Common Stock | 9,891 | USD 4.04 | USD 39,960 | SEC filing ↗ |
| 2026-06-11 | Treace John T. | Purchase (P) | Common Stock | 22,887 | USD 4.04 | USD 92,463 | SEC filing ↗ |
| 2026-06-10 | Treace John T. | Purchase (P) | Common Stock | 14,715 | USD 4.02 | USD 59,154 | SEC filing ↗ |
| 2026-06-10 | Treace John T. | Purchase (P) | Common Stock | 29,430 | USD 4.02 | USD 118,309 | SEC filing ↗ |
| 2026-06-01 | Treace John T. | Purchase (P) | Common Stock | 50,000 | USD 3.56 | USD 178,000 | SEC filing ↗ |
| 2026-05-28 | Treace John T. | Purchase (P) | Common Stock | 61,202 | USD 3.02 | USD 184,830 | SEC filing ↗ |
| 2026-05-27 | Treace John T. | Purchase (P) | Common Stock | 49,810 | USD 2.87 | USD 142,955 | SEC filing ↗ |
| 2026-05-26 | Treace John T. | Purchase (P) | Common Stock | 4,508 | USD 2.79 | USD 12,577 | SEC filing ↗ |
| 2026-05-14 | Treace John T. | Purchase (P) | Common Stock | 61,750 | USD 2.62 | USD 161,785 | SEC filing ↗ |
| 2026-05-13 | Treace John T. | Purchase (P) | Common Stock | 49,013 | USD 2.46 | USD 120,572 | SEC filing ↗ |
| 2026-05-12 | Treace John T. | Purchase (P) | Common Stock | 43,000 | USD 2.17 | USD 93,310 | SEC filing ↗ |
| 2025-03-04 | Treace John T. | Purchase (P) | Common Stock | 60,000 | USD 8.73 | USD 523,800 | SEC filing ↗ |
Form 4 evidence
51 transaction lines in the latest 365-day window; 451 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | Elder Scot Michael | Tax withholding (F) | Common Stock | 25,457 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-24 | Treace John T. | Purchase (P) | Common Stock | 11,000 | USD 4.34 | USD 47,740 | SEC filing ↗ |
| 2026-08-21 | Treace John T. | Purchase (P) | Common Stock | 5,000 | USD 4.35 | USD 21,750 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | Elder Scot Michael | Tax withholding (F) | Common Stock | 25,457 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-24 | Treace John T. | Purchase (P) | Common Stock | 11,000 | USD 4.34 | USD 47,740 | SEC filing ↗ |
| 2026-08-21 | Treace John T. | Purchase (P) | Common Stock | 5,000 | USD 4.35 | USD 21,750 | SEC filing ↗ |
| 2026-08-20 | Treace John T. | Purchase (P) | Common Stock | 39,944 | USD 4.44 | USD 177,351 | SEC filing ↗ |
| 2026-08-09 | Scanlan Sean F. | Tax withholding (F) | Common Stock | 9,814 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-09 | Hair Mark | Tax withholding (F) | Common Stock | 37,102 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-09 | Elder Scot Michael | Tax withholding (F) | Common Stock | 16,253 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-11 | Treace John T. | Purchase (P) | Common Stock | 9,891 | USD 4.04 | USD 39,960 | SEC filing ↗ |
| 2026-06-11 | Treace John T. | Purchase (P) | Common Stock | 22,887 | USD 4.04 | USD 92,463 | SEC filing ↗ |
| 2026-06-10 | Treace John T. | Purchase (P) | Common Stock | 14,715 | USD 4.02 | USD 59,154 | SEC filing ↗ |
| 2026-06-10 | Treace John T. | Purchase (P) | Common Stock | 29,430 | USD 4.02 | USD 118,309 | SEC filing ↗ |
| 2026-06-01 | Treace John T. | Purchase (P) | Common Stock | 50,000 | USD 3.56 | USD 178,000 | SEC filing ↗ |
| 2026-05-28 | Treace John T. | Purchase (P) | Common Stock | 61,202 | USD 3.02 | USD 184,830 | SEC filing ↗ |
| 2026-05-27 | Treace John T. | Purchase (P) | Common Stock | 49,810 | USD 2.87 | USD 142,955 | SEC filing ↗ |
| 2026-05-26 | Treace John T. | Purchase (P) | Common Stock | 4,508 | USD 2.79 | USD 12,577 | SEC filing ↗ |
| 2026-05-19 | Kiernan Jane E | Award / grant (A) | Common Stock | 30,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-19 | Jain Deepti | Award / grant (A) | Common Stock | 30,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-19 | Hanna Betsy | Award / grant (A) | Common Stock | 30,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-19 | HAMILTON LAWRENCE W | Award / grant (A) | Common Stock | 30,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-19 | Berry Lance A | Award / grant (A) | Common Stock | 30,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-19 | BAKEWELL JOHN K | Award / grant (A) | Common Stock | 30,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-14 | Treace John T. | Purchase (P) | Common Stock | 61,750 | USD 2.62 | USD 161,785 | SEC filing ↗ |
| 2026-05-13 | Treace John T. | Purchase (P) | Common Stock | 49,013 | USD 2.46 | USD 120,572 | SEC filing ↗ |
| 2026-05-12 | Treace John T. | Purchase (P) | Common Stock | 43,000 | USD 2.17 | USD 93,310 | SEC filing ↗ |
| 2026-04-17 | Hair Mark | Tax withholding (F) | Common Stock | 11,547 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-04-01 | Hair Mark | Award / grant (A) | Common Stock | 100,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-10 | Treace John T. | Tax withholding (F) | Common Stock | 5,021 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-10 | Scanlan Sean F. | Tax withholding (F) | Common Stock | 1,396 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-10 | Hair Mark | Tax withholding (F) | Common Stock | 3,695 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-10 | Elder Scot Michael | Tax withholding (F) | Common Stock | 1,675 | USD 0.00 | USD 0 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-19 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | TMCI |
| CIK | 0001630627 |
| Sector | Healthcare |
| Industry | Medical Devices Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 451 transaction lines from 2021-04-27 to 2026-09-30 48 P purchase lines · 201 S sale lines · 202 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.